Ketamine Infusion Preparation for Status Epilepticus
For refractory status epilepticus, prepare ketamine by diluting to 1-2 mg/mL concentration: transfer 10 mL from a 50 mg/mL vial (or 5 mL from a 100 mg/mL vial) into 500 mL of normal saline or 5% dextrose, then administer as a bolus of 1-2 mg/kg followed by continuous infusion starting at 0.9-1.0 mg/kg/hour, titrating upward every 15 minutes until seizure cessation. 1
Preparation Algorithm
Step 1: Dilution for Infusion
- Never inject the 100 mg/mL concentration intravenously without dilution 1
- Standard dilution (1 mg/mL): Aseptically transfer 10 mL from 50 mg/mL vial OR 5 mL from 100 mg/mL vial into 500 mL of either:
- 0.9% Sodium Chloride (Normal Saline), OR
- 5% Dextrose in Water 1
- Concentrated dilution (2 mg/mL): Use 250 mL bag instead of 500 mL when fluid restriction required 1
- Use immediately after dilution 1
- Inspect for particulate matter and discoloration before use; discard if present 1
Step 2: Loading Dose Administration
- Bolus dose: 1-2 mg/kg IV over 1-2 minutes 2, 3
- Administer slowly to avoid respiratory depression and enhanced vasopressor response 1
- Have airway equipment immediately available 1
Step 3: Maintenance Infusion
- Starting rate: 0.9-1.0 mg/kg/hour minimum 2, 3
- Titration: Increase by 1 mg/kg/hour increments every 15 minutes until seizures stop 3
- Maximum reported doses: Up to 10.5 mg/kg/hour in literature, though typical effective range is 2-3 mg/kg/hour 4, 5
- Alternative dosing from FDA label: 0.1-0.5 mg/minute (approximately 0.006-0.03 mg/kg/min for 70kg adult) for general anesthesia maintenance 1
Critical Timing Considerations
Initiate ketamine within 3-4 days of status epilepticus onset for optimal efficacy 5, 2:
- Responders received ketamine at mean 3.2 days vs. 4.3 days for non-responders 5
- No likely responses observed when ketamine introduced ≥8 days after SE onset 2
- Earlier administration (within 12 hours) associated with improved seizure control 3
Monitoring Requirements
Continuous monitoring is mandatory 1:
- Vital signs and cardiac function continuously
- Oxygen saturation
- Respiratory status (prepare for bag-valve-mask ventilation or intubation)
- EEG monitoring to confirm seizure cessation
- Metabolic acidosis parameters with prolonged infusion 4
Safety Precautions
Pre-Administration
- Administer antisialagogue prior to induction to manage salivation 1
- Ensure emergency airway equipment immediately available 1
- Have benzodiazepines available for emergence reactions 1
During Infusion
- Respiratory depression risk: 22% transient hypoxia rate reported 6
- Hemodynamic effects: Monitor for both hypertension and hypotension 1
- Metabolic acidosis: Particular concern with high-dose, prolonged infusions (>5 days) 4
- Discontinuation due to adverse events is rare (0.7%) 5
Efficacy Expectations
- Overall seizure cessation rate: 64% (95% CI 49-76%) 5
- Permanent control: 57% of episodes 2
- Pediatric efficacy: 51% seizure cessation 7
- Mortality reduction: 16% when SE controlled within 24 hours of ketamine initiation vs. 56% when not controlled 2
Common Pitfalls to Avoid
- Underdosing: Starting below 0.9 mg/kg/hour is ineffective 2, 3
- Delayed initiation: Waiting beyond 8 days significantly reduces efficacy 2
- Inadequate dilution: Never give 100 mg/mL concentration IV without dilution 1
- Failure to prepare for intubation: Despite ketamine potentially avoiding intubation, 31% may require bag-valve-mask support 6
- Premature discontinuation: Average effective infusion duration is 5 days 5
Advantages Over Traditional Anesthetics
- Avoids intubation: Can be used in general ward settings without ICU transfer 8, 9
- Shorter ICU stay: 4 days mechanical ventilation vs. 14 days with pentobarbital 10
- Lower hypotension risk: 42% vs. 77% with barbiturates 10
- Targets NMDA receptors: Effective when GABA receptor internalization causes benzodiazepine resistance 3